Modelling adipose tissue-cancer crosstalk: a three-dimensional perspective
Strusi G., Suelzu CM., Stebbing J.
Narrative Review, published in Oncogene (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Oncogene (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41708953
- PMCID
- PMC12953150
- DOI
- 10.1038/s41388-026-03697-w
- Citations
- 1
Abstract (original English)
Innovative three-dimensional (3D) systems have become a focus of research due to their ability to better mimic cell-cell and cell-extracellular matrix interactions. Current advances in 3D modelling have the potential to transform pre-clinical research by providing a more biologically relevant recapitulation of the in vivo cell environment. Among the published 3D platforms there is a lack of adipose tissue and cancer complex models. Primarily thought to function in triglyceride storage, protection and heat production, adipose tissue is now recognised as a complex and dynamic endocrine organ that secretes factors such as free fatty acids and adipokines, which have been shown to play a role in carcinogenesis. Obesity, a major cause of adipose tissue dysfunction, has also been strongly linked to the development of several types of cancer. 3D model technologies offer an innovative way to investigate adipose tissue-cancer crosstalk by mimicking in vivo conditions. This review aims to present a perspective on the adipose tissue-cancer dynamics and provide an overview of the current 3D models used to reliably reproduce the adipose tissue-cancer interaction in vitro.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.